This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carney, D. N. Articles by Minna, J. D. Search for Related Content PubMed PubMed Citation Articles by Carney, D. N. Articles by Minna, J. D.

Selective Stimulation of Small Cell Lung Cancer Clonal Growth by Bombesin and Gastrin-releasing Peptide¹

NCI-Navy Medical Oncology Branch, Division of Cancer Treatment, National Cancer Institute, and Naval Hospital, Bethesda, Maryland 20814-5105 [D. N. C., F. C., J. D. M.]; Department of Biochemistry, George Washington University School of Medicine and Health Science, Washington, DC 20037 [T. W. M.]

Human small cell lung cancers (SCLC) produce and secrete the regulatory peptide bombesin (BN) or its mammalian counterpart gastrinreleasing peptide (GRP). In addition, several SCLC tumor lines have been shown to express high affinity receptors for BN/GRP. On the basis of these findings, we investigated the effect of exogenously added BN and GRP on the soft agarose colony growth of a panel of human cell lines. In serum-free defined medium, colony formation of 9 of 10 SCLC cell lines was stimulated up to 150-fold by BN or GRP, with peak colony stimulation observed at 50 nM BN. In contrast, no stimulatory effect of BN was observed on nine non-SCLC cell lines. Although no stimulation of colony growth by BN was seen in serum-supplemented medium, addition of BN to the serum-free medium increased cloning efficiency to that achieved by serum in most of the SCLC cell lines. GRP 1–27, the active mammalian analogue of Bn, stimulated colony growth of SCLC cells similar to the manner of BN, while the physiologically inactive BN analogue, des-Leu (13)-Met (14)-BN, had no effect on colony growth. No correlation was observed in SCLC cell lines between the response of these cells to exogenous BN and the amount of cellular BN/GRP produced or the presence of BN receptors. These data suggest that BN/GRP may in some instances function as an autocrine growth factor for SCLC and indicate new ways for modulating SCLC growth in patients with this tumor.

¹ The opinions or assertions herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Navy or the Department of Defense.

² To whom requests for reprints should be addressed, at Mater Hospital, Dublin 7, Ireland.

Received 5/ 5/86. Revised 10/ 3/86. Accepted 10/14/86.

This article has been cited by other articles:

				S. Sorhaug, A. Langhammer, H. L. Waldum, K. Hveem, and S. Steinshamn Increased serum levels of chromogranin A in male smokers with airway obstruction Eur. Respir. J., September 1, 2006; 28(3): 542 - 548. [Abstract] [Full Text] [PDF]

				J. B. Engel, G. Keller, A. V. Schally, G. Halmos, B. Hammann, and A. Nagy Effective Inhibition of Experimental Human Ovarian Cancers with a Targeted Cytotoxic Bombesin Analogue AN-215 Clin. Cancer Res., March 15, 2005; 11(6): 2408 - 2415. [Abstract] [Full Text] [PDF]

				P.-W. Chen and G. S. Kroog Alterations in Receptor Expression or Agonist Concentration Change the Pathways Gastrin-Releasing Peptide Receptor Uses to Regulate Extracellular Signal-Regulated Kinase Mol. Pharmacol., December 1, 2004; 66(6): 1625 - 1634. [Abstract] [Full Text] [PDF]

				M. Z. Fang, C. Liu, Y. Song, G.-Y. Yang, Y. Nie, J. Liao, X. Zhao, Y. Shimada, L.-D. Wang, and C. S. Yang Over-expression of gastrin-releasing peptide in human esophageal squamous cell carcinomas Carcinogenesis, June 1, 2004; 25(6): 865 - 871. [Abstract] [Full Text] [PDF]

				J. C. Reubi Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy Endocr. Rev., August 1, 2003; 24(4): 389 - 427. [Abstract] [Full Text] [PDF]

				C. Van de Wiele, F. Dumont, R. A. Dierckx, S. H. Peers, J. R. Thornback, G. Slegers, and H. Thierens Biodistribution and Dosimetry of 99mTc-RP527, a Gastrin-Releasing Peptide (GRP) Agonist for the Visualization of GRP Receptor-Expressing Malignancies J. Nucl. Med., November 1, 2001; 42(11): 1722 - 1727. [Abstract] [Full Text] [PDF]

				S. I. Ahmed, J. Thompson, J. M. Coulson, and P. J. Woll Studies on the Expression of Endothelin, Its Receptor Subtypes, and Converting Enzymes in Lung Cancer and in Human Bronchial Epithelium Am. J. Respir. Cell Mol. Biol., April 1, 2000; 22(4): 422 - 431. [Abstract] [Full Text]

				A. Chaudhry, J. A. Carrasquillo, I. L. Avis, N. Shuke, J. C. Reynolds, R. Bartholomew, S. M. Larson, F. Cuttitta, B. E. Johnson, and J. L. Mulshine Phase I and Imaging Trial of a Monoclonal Antibody Directed against Gastrin-releasing Peptide in Patients with Lung Cancer Clin. Cancer Res., November 1, 1999; 5(11): 3385 - 3393. [Abstract] [Full Text] [PDF]

				R. K. Ravi, A. Thiagalingam, E. Weber, M. McMahon, B. D. Nelkin, and M. Mabry Raf-1 Causes Growth Suppression and Alteration of Neuroendocrine Markers in DMS53 Human Small-Cell Lung Cancer Cells Am. J. Respir. Cell Mol. Biol., April 1, 1999; 20(4): 543 - 549. [Abstract] [Full Text]

				R. Markwalder and J. C. Reubi Gastrin-releasing Peptide Receptors in the Human Prostate: Relation to Neoplastic Transformation Cancer Res., March 1, 1999; 59(5): 1152 - 1159. [Abstract] [Full Text] [PDF]

				J. M. SIEGFRIED, M. A. A. DEMICHELE, J. D. HUNT, A. G. DAVIS, K. P. VOHRA, and J. M. PILEWSKI Expression of mRNA for Gastrin-Releasing Peptide Receptor by Human Bronchial Epithelial Cells . Association with Prolonged Tobacco Exposure and Responsiveness to Bombesin-like Peptides Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 358 - 366. [Abstract] [Full Text]